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Abstract In this study, there is a confirmed association
between cerebral infarction with migraine and Chlamydia
pneumoniae infection, but the association between
C. pneumoniae IgG antibodies and migraine in the general
population has not been investigated. C. pneumoniae IgG
antibody levels were compared in 329 adult Chinese
patients, who met the International Classification of
Headache Disorders 2nd Edition (ICHD II) criteria for
migraine, and in 329 healthy subjects. Factors such as
gender, age, smoking, consumption of pickle, and body
mass index were evaluated. One hundred and ninety-five
(59.2%) migraine sufferers and 70 (21.27%) controls were
C. pneumoniae IgG antibody-seropositive (P \ 0.05).
Based on a multivariate stepwise logistic model, the odds’
ratios for C. pneumoniae IgG antibody seropositivity, body
mass index, smoking, and consumption of pickle were
3.397 (P = 0.000), 0.858 (P = 0.014), 1.692 (P = 0.012),
and 5.469 (P = 0.0000), respectively. In conclusion,
C. pneumoniae IgG antibodies may be a risk factor for
migraine.
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Introduction
Migraine is a common type of headache with specific
characteristics, including unilaterality, throbbing pain,
photophobia or phonophobia, and nausea or vomiting [1].
Several large-scale epidemiological studies have revealed
that the prevalence of migraine ranges from 6 to 13% in the
general population [2–6].
Migraine is a recurrent neurovascular headache, but its
mechanism is still unclear; it may be influenced by genetic,
endocrine, neurological or immune mechanisms, as well as
by other relevant factors. Headaches, in particular
migraine, are known to be independent risk factors for
ischemic stroke [4–13]. The association between migraine
and stroke is more prominent in young women, particu-
larly, in those taking oral contraceptives [8–11]. However,
in middle aged and elderly adults of either sex, the asso-
ciation is controversial. Several epidemiological studies
have indicated that severe headache and migraine should
be considered as risk factors for future stroke, prior to the
age of 70 [5, 12].
Chlamydia pneumoniae is an important pathogen in
infections of the respiratory tract [13] and numerous
reports have recently suggested its association with
atherosclerosis. Infection of the vascular wall with
C. pneumoniae has been linked to ischemic heart disease
[14–17] and stroke [18–24] in epidemiological studies as
well as in pathological studies using immunocytoche-
mistry, polymerase chain reaction (PCR), and electron
microscopy. In Japan, Miyashita et al. [25] reported a
significant elevation in C. pneumoniae antibody levels in a
patient with acute myocardial infarction and Kawamoto
et al. [26] showed a significant relation between athero-
sclerotic lesions and common carotid arteries. Kawashima
and Kawada [22] demonstrated a significant elevation
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of C. pneumoniae antibody levels in a patient with acute
ischemic stroke.
A correlation between cerebral infarction with migraine
and C. pneumoniae infection has been confirmed, but a
correlation between C. pneumoniae IgG antibody levels
and migraine has not been investigated in the general
population. We therefore investigated this relationship
between C. pneumoniae IgG antibodies and migraine.
Subjects and methods
Three hundred and twenty-nine Chinese patients attending
our hospital out-patient department between September
2005 and December 2007 and who met the International
Classification of Headache Disorders 2nd Edition (ICHD
II) criteria for migraine were included in the study. There
were 112 men and 217 women. Their ages ranged from 20
to 42 years (mean age 29.2 ± 8.2 years). Twenty patients
had cerebellar atrophy, 30 had migraine with aura, 19
experienced bilateral pain, and 25 patients had relevant
family histories. Ninety-one patients smoked ([5 years,
[15 packs/month), 253 patients ate pickle ([3 years,
[30 g/day). The average body mass index was 23.82 ±
1.56 kg/m2. The control group consisted of 329 healthy
subjects, including 133 men and 196 women, aged between
20 and 44 years old (mean age 31.2 ± 9.2 years). Of these,
96 smoked, 103 ate salted, preserved foods, and the aver-
age body mass index was 23.81 ± 1.91 kg/m2. Individuals
with recent histories of respiratory tract infections were
excluded (Table 1).
Specimen collection
All blood samples were taken and separated in the morning.
Experimental methods
Infection was determined by measuring anti-C. pneumoniae
IgG-specific antibody levels (Cp IgG index) using an
enzyme-linked immunosorbent assay method (‘‘HITAZYME
C. pneumoniae’’, Hitachi Chemical Co. Ltd., Tokyo, Japan).
Levels were measured in serum from fasting blood, which had
been preserved at -70C. Levels below the 1.10 Cp IgG index
were classified as seronegative and those above 1.10 as
seropositive [27].
Statistical analysis
The results are shown as mean value ± standard deviation.
The results were analyzed statistically using SPSS 10.0J
(Statistical Package for Social Science Inc., Chicago, IL,
USA) and compared using v2 tests. A value of P \ 0.05
was considered significant. The relationships between the
presence of migraine and a positive Cp IgG index, gender
(female 0; male 1), age, body mass index (BMI: body
weight/height2), smoking, and consumption of pickle were
examined by multiple logistic regression analysis.
Results
One hundred and ninety-five (59.2%) migraine patients and
70 (21.27%) controls were Cp IgG antibody-seropositive.
Based on multivariate stepwise logistic regression analysis,
the odds’ ratios for C. pneumoniae IgG antibody positivity,
body mass index, smoking, and consumption of pickle
were 3.397 (95% CI: 2.395–4.817, P = 0.000), 0.858 (95%
CI: 0.760–0.969, P = 0.014), 1.692 (95% CI: 1.124–2.547,
P = 0.012), and 5.469 (95% CI: 3.631–8.237, P = 0.0000),
respectively (Tables 2, 3).
Discussions
Migraine is a debilitating recurrent primary headache dis-
order, but its pathogenesis is still unclear. Migraine
headaches have a complex pathophysiology and both vas-
cular and neural theories have been proposed. One
hypothesis suggests that the process begins with a series of
destabilizing events within the brain that trigger cortical
spreading depression (CSD) [28]. CSD can cause both
migraine aura and trigeminal activation, which, in turn,








Gender, male, N 112 133 0.5
Age (years) 29.2 ± 8.2 31.2 ± 9.2 0.000
Smoking, N (over 5 years,
above 15 packs/month)
91 96 0.98
Pickle, N (over 3 years,
above 30 g/day)
253 103 0.000
Body mass index (kg/m2) 23.82 ± 1.56 23.81 ± 1.91 0.000
Table 2 Chlamydia pneumoniae IgG antibodies in patients and
controls
Group Seropositivity Negative Seropositivity
rates (%)
Study group 195 134 59.2
Control group 70 259 21.27
Migraine group compared with control group: v2 = 98.7205,
P \ 0.005
122 J Headache Pain (2009) 10:121–124
123
promotes neuropeptide release and triggers peripheral and
central mechanisms that promote headache and autonomic
activation. Susceptibility to CSD and to migraine is, in
part, genetically determined. The best evidence to date
comes from certain subtypes of migraine with aura, in
which, point mutations in genes controlling the transloca-
tion of calcium, sodium and potassium have been
implicated. When the dura mater cranial vascular wall by
stimulating the trigeminal nerve endings, vasoactive pep-
tide substances such as substance P, calcitonin gene-related
peptide, and neurokinin are released [29, 30], causing
neurogenic inflammation. Even minor chemical or
mechanical stimulation of the sensitized trigeminal nerve
also causes excessive excitement. Injury receptors at tri-
geminal nerve endings can stimulate the trigeminal nerve,
thereby causing headache, activating the autonomic ner-
vous system, and giving rise to symptoms such as nausea
and vomiting. Trigeminal nerve inflammation and allergic
trigeminal nerve provide a theoretical basis for migraine
[31, 32]. C. pneumoniae IgG antibody production follow-
ing infection can lead to inflammation and sensitization of
the trigeminal nerve, so leading to migraine attack.
The results of this study showed that 195 (59.2%) migraine
patients and 70 (21.27%) controls were C. pneumoniae
antibody-seropositive, while Nabipour et al. found a sero-
positivity rate of 37.7% in healthy humans. The discrepancy
between these results could be related to differences in
case selection, the number of cases, or to regional differences
[33].
Conclusion
The results of this study suggest that there is a correlation
between C. pneumoniae IgG antibodies and migraine. It is
possible that C. pneumoniae IgG antibodies may damage
the brain vasculature, promote atherosclerosis and disrupt
endothelial cell function, thereby stimulating vasospasm
and damaging the blood–brain barrier. Changes in the
environment can also stimulate a migraine attack due to the
inflammation and sensitization of the trigeminal nerve
caused directly by C. pneumoniae IgG antibodies.
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